MentionFox
Home › Executive changes › CareDx, Inc.
Leadership changes · CDNA · SEC Form 8-K, Item 5.02

Leadership changes at CareDx, Inc. (2026)

Before you join, sell to or invest in CareDx, Inc.

MentionFox check on CareDx, Inc.: only 1 source on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/caredx

Check CareDx, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about CareDx, Inc.?

Who joined and who left CareDx, Inc. (CDNA)? 1 appointment and 1 departure reported on 2026-02-25, each cited to the company's own filing.

Keith Kennedy was named Chief Financial Officer and Chief Operating Officer of CareDx, Inc., succeeding Nathan Smith, effective February 26, 2026. As of November 14, 2026, CareDx, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on February 25, 2026, naming 1 appointment and 1 departure (Form 8-K, February 25, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

Gagnon Securities LLC also filed stake reports on 4 other companies ↓

Sell to companies like CareDx, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes2
In (appointed)1
Out (departing)1
Latest filing2026-02-25

CareDx, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-02-25. It names 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as CareDx, Inc. files it.

Also on the record for CareDx, Inc.

DateRecordFigureOur pageSource
November 10, 2026Stake report, Schedule 13G, by STATE STREET CORPORATION5.1% of the class5%+ stakesSource
August 14, 2026Stake report, Schedule 13G/A, by Baron Capital Group, Inc.3.75% of the class5%+ stakesSource
August 7, 2026Stake report, Schedule 13G, by STATE STREET CORPORATION4.8% of the class5%+ stakesSource
August 7, 2026Stake report, Schedule 13G/A, by Neil Gagnon4.4% of the class5%+ stakesSource
July 27, 2026Stake report, Schedule 13G/A, by BlackRock, Inc.9% of the class5%+ stakesSource
July 7, 2026Acquired Naveris, Inc.—AcquisitionSource
July 1, 2026Acquired Naveris, Inc.$171.70MAcquisitionSource
March 26, 2026Stake report, Schedule 13G/A, by The Vanguard Group—5%+ stakesSource
February 12, 2026Stake report, Schedule 13G/A, by Neil Gagnon5.9% of the class5%+ stakesSource
February 9, 2026Stake report, Schedule 13G, by STATE STREET CORPORATION5.3% of the class5%+ stakesSource
November 14, 2025Stake report, Schedule 13G, by Baron Capital Group, Inc.5.93% of the class5%+ stakesSource
October 30, 2025Stake report, Schedule 13G/A, by The Vanguard Group7.04% of the class5%+ stakesSource

Selling to them or working with them? See who runs CareDx, Inc. now and the warning signs.

Free to see. No signup.

Keep reading

More on CareDx, Inc. and the records around it.

CareDx, Inc. elsewhere on the record

Companies that share a holder

Want the whole picture on CareDx, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on CareDx, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on CareDx, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    13 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 13 records.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-02-25InChief Financial Officer and Chief Operating Officer2026-02-268-K/A, 2026-02-25
2026-02-25OutChief Financial Officer2026-02-258-K/A, 2026-02-25

Why did they leave? What the filings say

For each named departure below, the sentence from the company's own filing that gives a reason, word for word. Where a filing gives none, it says so here; nothing is inferred.

Who leads CareDx, Inc., as last reported?

For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.

Selling to CareDx, Inc.?

New leaders reset buying decisions — get the Full Report on CareDx, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch CareDx, Inc.

Hiring for a seat like this?

Find people with the same kind of experience as the Chief Financial Officer and Chief Operating Officer at CareDx, Inc., with the record behind each one.

Find candidates like Chief Financial Officer and Chief Operating Officer at CareDx, Inc.

Every change, in the filing's words

Filed 2026-02-25 · 8-K/A

Appointed: Keith Kennedy, Chief Financial Officer and Chief Operating Officer, effective 2026-02-26

The Board of Directors of the Company has appointed Keith Kennedy as the Company's Chief Financial Officer and Chief Operating Officer, effective as of February 26, 2026.

Departing: Nathan Smith, Chief Financial Officer, effective 2026-02-25

On February 24, 2026, the Company announced Nathan Smith resigned from his position as the Company's Chief Financial Officer for personal reasons, effective as of the close of business on February 25, 2026 (the "Separation Date").

Also stated in this filing

  • In connection with such appointment, Mr. Kennedy has also been designated as the Company's "principal financial officer" and "principal accounting officer" for purposes under the Securities Exchange Act of 1934, as amended.
  • Mr. Kennedy, age 56, has served as the Company's Chief Operating Officer since September 2024.
  • Prior to joining the Company, Mr. Kennedy served as the Chief Financial Officer of PharmaLogic Holdings Corp from April 2022 to September 2024.
  • Mr. Kennedy served as Veractye, Inc.'s Chief Operating Officer from July 2019, as well as its Chief Financial Officer from December 2016, until his retirement in May 2021, as well as its Secretary from November 2017 to July 2020.
  • Prior to joining Veracyte, Mr. Kennedy provided strategic counsel and consulting services from his consulting practice from September 2015 to November 2016, including advisory services to Pennant Park Investment Advisors.
  • Mr. Kennedy served as President, Chief Executive Officer and Director of MCG Capital Corporation, a publicly traded business development company, from April 2014 until its merger with Pennant Park Floating Rate Capital Ltd in August 2015.
  • Mr. Kennedy joined MCG Capital Corporation in February 2012 as an Executive Vice President and Managing Director, served as its Chief Financial Officer and Treasurer from May 2012 to March 2014, and its President from March to April 2014.

Tools for this story

Each opens in a new tab, filled in for CareDx, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/caredx
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
CareDx, Inc. CFO: Keith Kennedy succeeds Nathan Smith. MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/caredx